Wiley Blackwell

SHERPA: Unknown

People

  1. Bartlett
    Bartlett
  2. Dahi
    Dahi
  3. Palomba
    Palomba
  4. Perales
    Perales
  5. Yahalom
    Yahalom
  6. Jarnagin
    Jarnagin
  7. O'Reilly
    O'Reilly
  8. Batlevi
    Batlevi
  9. Chou
    Chou
  10. D'Angelica
    D'Angelica

Groups

  1. CTCR Scholars (27)
  2. MSK Grad Students (27)
  3. Master of Science in Clinical and Translational Cancer Research (27)
  4. Department of Medicine (21)
  5. Survivorship Research (18)
  6. Hematologic Malignancies, Division of (14)
  7. Surgery (13)
  8. Epidemiology and Biostatistics (12)
  9. Biostatistics Service (11)
  10. Center for Hematologic Malignancies (11)
Search Within
  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Journal Article (14)
  2. Meeting Abstract (9)
  3. Review (2)
  4. Book Section (1)
  5. Correspondence (1)
Groups
  1. CTCR Scholars (27)
  2. MSK Grad Students (27)
  3. Master of Science in Clinical and Translational Cancer Research (27)
  4. Department of Medicine (21)
  5. Survivorship Research (18)
  6. Hematologic Malignancies, Division of (14)

More Groups

People
  1. Edmund Bartlett (8)
  2. Parastoo Dahi (8)
  3. Maria Palomba (7)
  4. Joachim Yahalom (6)
  5. Miguel-Angel Perales (6)
  6. Anna Varghese (5)

More People

Years
  1. 2025 (1)
  2. 2023 (6)
  3. 2022 (2)
  4. 2021 (6)
  5. 2020 (2)
  6. 2019 (7)

More Years

Publications
  1. Hematological Oncology (9)
  2. Cancer (8)
  3. Journal of Surgical Oncology (6)
  4. BJU International (1)
  5. Cancer Medicine (1)
  6. Clinical Guide to Transplantation in Lymphoma (1)

More Publications

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment patterns and survival in patients with early-onset pancreatic cancer
    Journal Article

    Saadat, L. V.; Chou, J. F.; Gonen, M.; Soares, K. C.; Kingham, T. P.; Varghese, A. M.; Jarnagin, W. R.; D’Angelica, M. I.; Drebin, J. A.; O’Reilly, E. M.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (CHL) after autologous transplantation: 5‐year overall survival from the phase 2 CheckMate 205 study
    Meeting Abstract

    Ansell, S. M.; Bröckelmann, P. J.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G. P.; Cohen, J. B.; De Boer, J. P.; Kuruvilla, J.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)
    Journal Article

    Broman, K. K.; Hughes, T.; Dossett, L.; Sun, J.; Kirichenko, D.; Carr, M. J.; Sharma, A.; Bartlett, E. K.; Nijhuis, A. A. G.; Thompson, J. F.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • The emerging role of immunotherapy for the treatment of sarcoma
    Review

    Klemen, N. D.; Kelly, C. M.; Bartlett, E. K.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
    Journal Article

    McIntyre, C. A.; Lawrence, S. A.; Richards, A. L.; Chou, J. F.; Wong, W.; Capanu, M.; Berger, M. F.; Donoghue, M. T. A.; Yu, K. H.; Varghese, A. M.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study
    Journal Article

    Naik, S.; Riches, M.; Hari, P.; Kim, S.; Chen, M.; Bachier, C.; Shaughnessy, P.; Hill, J.; Ljungman, P.; Battiwalla, M.; more...
    Transplant Infectious Disease (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation impacts on immune evasive mechanisms in relapsed/refractory diffuse large B‐cell lymphoma – A single center experience
    Meeting Abstract

    Sauter, C. S.; Lin, R. J.; Ho, C.; Devlin, S. M.; Maloy, M. A.; Perales, M.; Dahi, P. B.; Schoder, H.; Jakubowski, A. A.; Barker, J. N.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save